MetLife, Inc. (NYSE:MET) Receives Average Rating of “Moderate Buy” from Analysts

MetLife, Inc. (NYSE:METGet Free Report) has been given an average recommendation of “Moderate Buy” by the thirteen analysts that are covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $77.23.

MET has been the topic of several research analyst reports. The Goldman Sachs Group upgraded shares of MetLife from a “neutral” rating to a “buy” rating and boosted their price target for the company from $70.00 to $80.00 in a report on Monday, January 8th. UBS Group decreased their price objective on shares of MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a report on Monday, February 5th. Wells Fargo & Company cut their target price on shares of MetLife from $85.00 to $83.00 and set an “overweight” rating for the company in a research report on Tuesday, February 6th. Morgan Stanley boosted their target price on shares of MetLife from $79.00 to $80.00 and gave the stock an “overweight” rating in a research report on Thursday, November 2nd. Finally, Keefe, Bruyette & Woods cut their price objective on shares of MetLife from $79.00 to $77.00 and set an “outperform” rating for the company in a research report on Thursday, December 7th.

Read Our Latest Report on MET

Hedge Funds Weigh In On MetLife

Several institutional investors and hedge funds have recently added to or reduced their stakes in MET. BlackRock Inc. increased its position in shares of MetLife by 1.1% during the second quarter. BlackRock Inc. now owns 55,059,523 shares of the financial services provider’s stock worth $3,112,515,000 after buying an additional 578,699 shares during the period. Morgan Stanley lifted its stake in shares of MetLife by 3.7% in the fourth quarter. Morgan Stanley now owns 11,584,674 shares of the financial services provider’s stock valued at $838,383,000 after buying an additional 418,477 shares in the last quarter. Pzena Investment Management LLC lifted its position in shares of MetLife by 118.1% during the third quarter. Pzena Investment Management LLC now owns 10,108,992 shares of the financial services provider’s stock valued at $635,957,000 after purchasing an additional 5,474,449 shares in the last quarter. Norges Bank bought a new position in shares of MetLife during the fourth quarter valued at about $558,460,000. Finally, Macquarie Group Ltd. lifted its position in shares of MetLife by 6.2% during the first quarter. Macquarie Group Ltd. now owns 7,466,099 shares of the financial services provider’s stock valued at $432,585,000 after purchasing an additional 436,260 shares in the last quarter. Institutional investors own 88.14% of the company’s stock.

MetLife Trading Up 1.6 %

MetLife stock opened at $68.55 on Tuesday. The company’s fifty day simple moving average is $67.22 and its 200-day simple moving average is $64.13. The company has a quick ratio of 0.13, a current ratio of 0.16 and a debt-to-equity ratio of 0.53. MetLife has a 12 month low of $48.95 and a 12 month high of $73.12. The stock has a market cap of $50.74 billion, a P/E ratio of 37.46, a P/E/G ratio of 0.56 and a beta of 1.04.

MetLife Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 14th. Stockholders of record on Tuesday, February 6th will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 3.03%. The ex-dividend date of this dividend is Monday, February 5th. MetLife’s dividend payout ratio (DPR) is presently 113.66%.

MetLife Company Profile

(Get Free Report

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.